Vicki L. Rothman

2.3k citations

48 papers · 2.1k indexed · h-index 25

Co-authors: George P. Tuszynski Xiaohua Qian Karen A. Knudsen Thomas J. Wang Simeón Margolis David M. Capuzzi Mark S. Granick Roberto F. Nicosia
Topics: Angiogenesis and VEGF in Cancer (31 papers)Protease and Inhibitor Mechanisms (21 papers)Cell Adhesion Molecules Research (9 papers)
Cited by: Immunology and Allergy Cancer Research Hematology
Journals: Science Journal of Biological Chemistry Journal of Clinical Investigation
Partner nations: United States Italy Malaysia

In The Last Decade

Vicki L. Rothman

47 papers receiving 2.0k citations

Peers

Countries citing papers authored by Vicki L. Rothman

Since Specialization

Citations

This map shows the geographic impact of Vicki L. Rothman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicki L. Rothman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicki L. Rothman more than expected).

Fields of papers citing papers by Vicki L. Rothman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicki L. Rothman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicki L. Rothman. The network helps show where Vicki L. Rothman may publish in the future.

Co-authorship network of co-authors of Vicki L. Rothman

This figure shows the co-authorship network connecting the top 25 collaborators of Vicki L. Rothman. A scholar is included among the top collaborators of Vicki L. Rothman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vicki L. Rothman. Vicki L. Rothman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	G-Protein-Coupled Receptor-Associated Sorting Protein 1 Overexpression Is Involved in the Progression of Benign Prostatic Hyperplasia, Early-Stage Prostatic Malignant Diseases, and Prostate Cancer 2024 ·Cancers ·(unknown),Shuanzeng Wei,(unknown),George Tuszynski,Vicki L. Rothman,(unknown),Jeff Yang,F.N. Chang	0
2	Angiocidin induces differentiation of acute myeloid leukemia cells 2013 ·Experimental and Molecular Pathology ·George P. Tuszynski,Vicki L. Rothman	2
3	G-protein coupled receptor-associated sorting protein 1 (GASP-1), a ubiquitous tumor marker 2012 ·Experimental and Molecular Pathology ·Xiaoyi Zheng,F.N. Chang,Xinmin Zhang,Vicki L. Rothman,George P. Tuszynski	13
4	Angiocidin inhibits breast cancer proliferation through activation of epidermal growth factor receptor and nuclear factor kappa (NF-ĸB) 2011 ·Experimental and Molecular Pathology ·(unknown),Irene Sargiannidou,Sneha Patel,(unknown),Vicki L. Rothman,George P. Tuszynski	7
5	Effect of VP12 and viperistatin on inhibition of collagen receptors: dependent melanoma metastasis 2009 ·Cancer Biology & Therapy ·Izabela Staniszewska,Erin Walsh,Vicki L. Rothman,Ariel Gaathon,George P. Tuszynski,Juan J. Calvete,Philip Lazarovici,Cezary Marcinkiewicz	51
6	The Novel Angiogenic Inhibitor, Angiocidin, Induces Differentiation of Monocytes to Macrophages 2008 ·Cancer Research ·(unknown),Vicki L. Rothman,(unknown),George P. Tuszynski	19
7	Antibody-directed targeting of angiostatin's receptor annexin II inhibits Lewis Lung Carcinoma tumor growth via blocking of plasminogen activation: Possible biochemical mechanism of angiostatin's action 2006 ·Experimental and Molecular Pathology ·Meena Sharma,Vicki L. Rothman,George P. Tuszynski,Mahesh C. Sharma	47
8	Reduction of angiocidin expression in human umbilical vein endothelial cells via siRNA silencing inhibits angiogenesis 2006 ·Experimental and Molecular Pathology ·Xiao Yang,Vicki L. Rothman,(unknown),George Tuszynski	8
9	Clinical significance of serum angiocidin levels in hepatocellular carcinoma 2006 ·Cancer Letters ·(unknown),Vicki L. Rothman,Ronnie T.P. Poon,George P. Tuszynski	12
10	Cloning and characterization of angiocidin, a tumor cell binding protein for thrombospondin‐1 2004 ·Journal of Cellular Biochemistry ·Jing Zhou,Vicki L. Rothman,Irene Sargiannidou,(unknown),(unknown),(unknown),Joel B. Sheffield,Mahesh C. Sharma,George P. Tuszynski	24
11	Thrombospondin-1 Promotes Proliferative Healing through Stabilization of PDGF 2002 ·Journal of Surgical Research ·(unknown),Quan P. Ly,Vicki L. Rothman,George P. Tuszynski	31
12	Thrombospondin 1 and Its Specific Cysteine-Serine-Valine-Threonine-Cysteine-Glycine Receptor in Fetal Wounds 1999 ·Annals of Plastic Surgery ·Jeffrey Roth,Joanne Sung,Mark S. Granick,Mark P. Solomon,Michael T. Longaker,Vicki L. Rothman,Roberto F. Nicosia,George P. Tuszynski	6
13	Thrombospondin-1 Is Elevated with both Intimal Hyperplasia and Hypercholesterolemia 1998 ·Journal of Surgical Research ·Jeffrey Roth,Vivian Gahtan,Jeffrey L. Brown,(unknown),Vanlila K. Swami,Vicki L. Rothman,Thomas N. Tulenko,George P. Tuszynski	81
14	Thrombospondin-1 and Its CSVTCG-Specific Receptor in Wound Healing and Cancer 1998 ·Annals of Plastic Surgery ·Jeffrey Roth,Daniel Albo,Vicki L. Rothman,Michael T. Longaker,Mark S. Granick,Charles D. Long,Mark P. Solomon,George P. Tuszynski	6
15	The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro. 1997 ·Journal of Clinical Investigation ·(unknown),Karsten Kuhn,(unknown),Vicki L. Rothman,George P. Tuszynski,Renato V. Iozzo,T L Swenson,Edward A. Fisher,Kevin Jon Williams	206
16	Inhibition of breast cancer progression by an antibody to a thrombospondin-1 receptor 1996 ·Surgery ·Thomas J. Wang,Xiaohua Qian,Mark S. Granick,Mark P. Solomon,Vicki L. Rothman,David Berger,George P. Tuszynski	33
17	Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells 1995 ·Cancer ·J. Pablo Arnoletti,Daniel Albo,Mark S. Granick,Mark P. Solomon,Analia Castiglioni,Vicki L. Rothman,George P. Tuszynski	57
18	Thrombospondin (TSP) and Transforming Growth Factor β 1 (TGF-β) Promote Human A549 Lung Carcinoma Cell Plasminogen Activator Inhibitor Type 1 (Pal-1) Production and Stimulate Tumor Cell Attachment in Vitro 1994 ·Biochemical and Biophysical Research Communications ·Daniel Albo,J. Pablo Arnoletti,Analia Castiglioni,Mark S. Granick,Mark P. Solomon,Vicki L. Rothman,George P. Tuszynski	43
19	The GPIIb-IIIa-like complex may function as a human melanoma cell adhesion receptor for thrombospondin 1989 ·Experimental Cell Research ·George P. Tuszynski,Jerzy Karczewski,Linda Smith,Andrew W. Murphy,Vicki L. Rothman,Karen A. Knudsen	39
20	Role of Thrombospondin in Hemostasis and Cell Adhesion 1987 ·Seminars in Thrombosis and Hemostasis ·George Tuszynski,Vicki L. Rothman,Andrew W. Murphy,Karen A. Knudsen	13

About Vicki L. Rothman

Vicki L. Rothman is a scholar working on Cancer Research, Immunology and Allergy and Hematology, having authored 48 papers that have together received 2.1k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (31 papers), Protease and Inhibitor Mechanisms (21 papers) and Cell Adhesion Molecules Research (9 papers). The work is most often cited by research in Immunology and Allergy (375 citations), Cancer Research (786 citations) and Hematology (284 citations). Vicki L. Rothman has collaborated with scholars based in United States, Italy and Malaysia. Frequent co-authors include George P. Tuszynski, Xiaohua Qian, Karen A. Knudsen, Thomas J. Wang, Simeón Margolis, David M. Capuzzi, Mark S. Granick, Roberto F. Nicosia, Mark P. Solomon and Daniel Albo. Their work appears in journals such as Science, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact